Amy's Foundation
Amy's Foundation is a 501(c)(3) nonprofit founded in 2024 in Indiana that funds ovarian cancer early detection research at Cleveland Clinic via community-driven donations, recurring giving, and a survivor advocacy program.
- Company typePrivate
- Founded2024
- HeadquartersFort Wayne, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Amy's Foundation does
Amy's Foundation is a 501(c)(3) nonprofit organization established in 2024 in Fort Wayne, Indiana, by Ron Martin in memory of his late wife Amy Louise Daniels Martin, who carried a BRCA-1 gene mutation and died of ovarian cancer in January 2024. The foundation's singular mission is to fund the development of the first early detection test for ovarian cancer, addressing the gap left by the absence of a screening tool comparable to mammography or Pap smears — a gap that contributes to a 30% five-year survival rate versus 90% for breast cancer and 92% for cervical cancer. The foundation operates a community-driven fundraising model, channeling donations through its website, a Venmo account (@amysfoundation), and the Generosity payment processor, with both one-time and recurring tiers starting at $1 monthly.
The organization's core product is research funding directed to Cleveland Clinic, specifically supporting Dr. Mariam AlHilli's study on integrin/syndecan signaling pathways as potential biomarkers for early detection in BRCA mutation carriers. Its secondary programs include the Amy's Allies volunteer advocacy program, which recruits ovarian cancer survivors and supporters to share personal stories on Instagram, Facebook, LinkedIn, YouTube, and TikTok, and a Salesforce-managed email/newsletter channel used for donor cultivation. The foundation has no proprietary technology product and does not sell goods or services; all revenue derives from charitable donations.
As of the first funding cycle, the foundation has raised approximately $17,482 from 318 donations against a $25,000 goal, deployed a 1-10 employee founder-led operating model, and operates exclusively within the United States. Competitive positioning rests on a tightly focused disease mandate, a personal founder narrative, and a named institutional research partner, rather than on scale advantages or distribution dominance in the broader nonprofit sector.
Amy's Foundation firmographics
Firmographics- Name
- Amy's Foundation
- Legal name
- Amy's Foundation, Inc
- Website
- https://amysfoundation.org
- Company type
- Private
- Founded year
- 2024
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Amy's Foundation is a 501(c)(3) nonprofit founded in 2024 in Indiana that funds ovarian cancer early detection research at Cleveland Clinic via community-driven donations, recurring giving, and a survivor advocacy program.
- Ownership category
- akta.pro rank
Amy's Foundation industry classification
Industry- Product category
- Ovarian Cancer Research Nonprofit Foundation
- NAICS
- Voluntary Health Organizations (813212), Grantmaking Foundations (813211)
- akta.pro primary industry
- Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS) (BPAGACAA)
- akta.pro secondary industry
- Health & Medical Research Grantmaking Foundations (BPAGAKAL)
Keywords
Where Amy's Foundation is headquartered
LocationHeadquarters
- HQ city
- Fort Wayne
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Amy's Foundation business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Operations, Marketing or Sales, Technology or R&D, Personnel, Others
Revenue model
- Donations: The organization accepts one-time and recurring donations through a secure third-party payment processor (Generosity). Donations are tax-deductible as the organization is a 501(c)(3) nonprofit.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | One time | First Funding Cycle goal of $25,000 for early detection research |
| Subscription | Monthly | Recurring donation options for monthly supporters |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels5 records
Amy's Foundation product offering
Product offeringCore offering
Amy's Foundation is a 501(c)(3) nonprofit that raises funds to support Cleveland Clinic's research, led by Dr. Mariam AlHilli, aimed at developing the first early detection test for ovarian cancer, with focus on integrin/syndecan biomarkers in BRCA mutation carriers. The foundation collects one-time and recurring donations through its website and Venmo, and runs the Amy's Allies social advocacy program to spread awareness.
Product overview
Amy's Foundation is a 501(c)(3) nonprofit organization focused on funding ovarian cancer early detection research. The organization operates primarily through its website platform, which combines donation collection (via one-time and recurring donation programs) with research advocacy. The core product is funding for Cleveland Clinic's ovarian cancer research, led by Dr. Mariam AlHilli, specifically targeting the development of the first early detection test for ovarian cancer. Supporting offerings include the Amy's Allies social advocacy program where volunteer survivors amplify awareness through social media.
Differentiator
Problem solved
Functional benefit
Products and services
- Ovarian Cancer Research Funding The foundation's primary mission product: funding Cleveland Clinic's research led by Dr. Mariam AlHilli to develop the first early detection test for ovarian cancer, including the investigation of integrin/syndecan biomarkers in BRCA mutation carriers.
- Donation Platform Website-based fundraising platform accepting one-time donations to fund ovarian cancer early detection research, processed through the third-party Generosity payment processor.
- Recurring Donation Program Monthly and weekly giving program allowing donors to contribute recurring amounts starting at $1 per week or month, with options to cover transaction fees, supporting ongoing ovarian cancer research funding.
- Amy's Allies Program Volunteer social media advocacy program where ovarian cancer survivors and supporters use their digital platforms to spread awareness, share resources, and amplify the foundation's mission year-round and during Ovarian Cancer Awareness Month.
Quantifiable outcome
- Currently at 70% of first $25,000 funding goal for Cleveland Clinic research
- +1 more outcomes
Companies that use Amy's Foundation
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Amy's Foundation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Integration2 records
Amy's Foundation partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Cleveland CliniccoreAmy's Foundation is raising funds to support Cleveland Clinic's groundbreaking research to develop the first early detection test for ovarian cancer. The research is led by Dr. Mariam AlHilli and focuses on investigating integrin/syndecan signaling pathways as potential biomarkers for early detection in BRCA mutation carriers. The study aims to examine ovarian tissues and blood samples to identify new detection methods.
- Dr. Mariam AlHillicoreDr. Mariam AlHilli is the lead researcher at Cleveland Clinic conducting the early detection ovarian cancer study. Her team is investigating whether changes in cell signaling (integrin/syndecan) found in breast tissues of BRCA mutation carriers are also present in ovarian tissues and whether these changes can serve as new biomarkers for early detection.
Scale indicators4 records
Recent moves5 records
Expansion highlights4 records
Amy's Foundation competitors and assessment
Company assessmentBroad incumbents
- Breast Cancer Research Foundation (BCRF): Large disease-specific research grantmaking foundation operating a model very similar to Amy's Foundation (donor-funded research grants to academic medical centers), but at vastly greater scale and focused on breast cancer. Useful benchmark for the scale trajectory Amy's Foundation could pursue.
- American Cancer Society: Largest U.S. cancer nonprofit funding broad research, including ovarian cancer programs. Overlaps with Amy's Foundation in donor pool and research grantmaking category but competes for the same ovarian cancer research dollars at vastly larger scale.
- Susan G. Komen: The dominant breast cancer research and awareness nonprofit, demonstrating the ceiling of a survivor-story-driven, single-disease grantmaking foundation. Comparable GTM motion (race fundraising, survivor storytelling) and grantmaking structure, though in a different cancer.
Direct peers
- Ovarian Cancer Research Alliance (OCRA): Largest U.S. nonprofit focused exclusively on ovarian cancer, combining research grantmaking with advocacy and patient support. Directly comparable mission (funding ovarian cancer research) and donor-driven nonprofit model.
- V Foundation for Cancer Research: Venture-style cancer research grantmaking foundation funding investigator-initiated studies across multiple cancer types. Comparable grantmaking nonprofit model, though broader in scope and substantially larger.
- National Ovarian Cancer Coalition (NOCC): Long-standing ovarian cancer nonprofit funding research, awareness, and survivor support programs. Mirrors Amy's Foundation's combination of research funding and survivor-led awareness, though at much larger scale.
- Pancreatic Cancer Action Network (PanCAN): Dedicated single-disease cancer research and advocacy nonprofit that has built a strong donor community around an underfunded cancer with poor survival rates. A useful comp for Amy's Foundation's strategic position — analogous disease severity, analogous gap in early detection.
- Stand Up To Cancer: High-profile cancer research funding collaborative supporting translational and early detection research. Similar model of channeling donor dollars into named research programs at major medical centers.
- Clearity Foundation: Ovarian cancer-specific nonprofit supporting biomarker-driven personalized medicine and early detection research. Closely aligned on the diagnostic/biomarker research thesis Amy's Foundation funds at Cleveland Clinic.
Regional players
- Ovarian Cancer Canada: Canadian national charity dedicated to ovarian cancer research, awareness, and support. Direct mission peer, but operates in a different geography (Canada vs. U.S.) and therefore does not compete for the same donor pool.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat3 records
Key risks6 records
Key highlights6 records
Customer concentration
Amy's Foundation social profiles
Digital presenceAmy's Foundation compliance and trust
Trust signalCompliance1 record
Amy's Foundation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Amy's Foundation leadership team
Management profileNumber of profiles
Profiles1 record
Amy's Foundation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Amy's Foundation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Amy's Foundation
What does Amy's Foundation do?
Amy's Foundation is a 501(c)(3) nonprofit that raises funds to support Cleveland Clinic's research, led by Dr. Mariam AlHilli, aimed at developing the first early detection test for ovarian cancer, with focus on integrin/syndecan biomarkers in BRCA mutation carriers. The foundation collects one-time and recurring donations through its website and Venmo, and runs the Amy's Allies social advocacy program to spread awareness.
Is Amy's Foundation a public or private company?
Amy's Foundation is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Amy's Foundation founded?
Amy's Foundation was founded in 2024. It employs 1 to 10 people.
Where is Amy's Foundation based?
Amy's Foundation is headquartered in Fort Wayne, United States, in the North America region.
How does Amy's Foundation make money?
One revenue line is on record: donations.
Who are Amy's Foundation's main competitors?
Broad incumbents on record are Breast Cancer Research Foundation (BCRF), American Cancer Society and Susan G. Komen. Direct peers are Ovarian Cancer Research Alliance (OCRA), V Foundation for Cancer Research, National Ovarian Cancer Coalition (NOCC), Pancreatic Cancer Action Network (PanCAN), Stand Up To Cancer and Clearity Foundation. Ovarian Cancer Canada is listed as a regional player.
Does Amy's Foundation have an API?
No public API is recorded for Amy's Foundation.
What industry is Amy's Foundation in?
Amy's Foundation's product category is Ovarian Cancer Research Nonprofit Foundation. Its primary akta.pro industry code is BPAGACAA, Disease-Specific Research & Support (e.g., Cancer, Diabetes, ALS), with a secondary code of BPAGAKAL, Health & Medical Research Grantmaking Foundations. Its NAICS code is 813212.